Skip to main content

Nemaura Medical Inc.

NMRDDelisted Mar 21, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001602078

Nemaura Medical Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Jan 9, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $280.9K in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
21
Q4 2023, −1 vs. previous quarter
13F value
$280.9K
Reported value at the end of Q4 2023
Superinvestors holding
0
At the end of Q4 2023

Superinvestors holding NMRD, Q4 2023

Go to the superinvestors tab

No superinvestor reported holding NMRD at the end of Q4 2023.

Latest insider trades

Open-market purchases and sales by Nemaura Medical Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 9, 2024 (view filing)5:30 PM ETJan 54 daysGhadar-Ghadr ArashChief Operating OfficerPPurchase+100.0K$0.14+$14.0KNew position100.0K after

Top 10 13F holders, Q4 2023

The largest institutional positions in Nemaura Medical Inc. at the end of Q4 2023; share changes are against Q3 2023.

See all 21 holders
Institutions holding NMRD in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Alyeska Investment Group, L.P.845,060$185.1K0.00%−997,505−54.1%Reduced
Vanguard Group Inc126,682$27.7K0.00%00.0%Unchanged
Geode Capital Management, LLC107,897$24.3K0.00%00.0%Unchanged
State Street Corp53,666$12.1K0.00%00.0%Unchanged
Citadel Advisors LLC41,693$9.38K0.00%+41,693New
Northern Trust Corp26,737$5.86K0.00%00.0%Unchanged
XTX Topco Ltd21,328$4.80K0.00%+21,328New
Two Sigma Securities, LLC17,403$3.81K0.00%+17,403New
UBS Group AG13,926$3.05K0.00%+13,841+16,283.5%Added
Tower Research Capital LLC (TRC)11,872$2.60K0.00%−68−0.6%Reduced